- Thomas Cleary
- Ashley Granot
- (Other Board members to be announced
publicly and then posted on the Website)
Thomas M Cleary MD, LAH Dubl, MB, BCh,
and NUI
Dr Cleary, a licensed physician, has been practicing medicine
for over 30 years. Trained in Dublin, Ireland and number of
universities worldwide he holds the qualifications LAH Dubl,
MB, BCh, and NUI. Dr. Cleary is a registered medical doctor
authorized to practice anywhere within the British Commonwealth
and Europe. Dr. Cleary is a Licensed Pharmacist within Europe
and is a European qualified person - regulatory. Dr. Cleary
has had many senior positions in the pharmaceutical industry
and finds his background in pharmacology very useful for developing
improved XPDT protocols for XYTOS. Dr. Cleary has wide commercial
experience and has been Chairman of several very well known
Health related organizations and has chaired three pharmaceutical
companies. Dr. Cleary is our senior physician and he has been
treating cancer patients with XPDT (the XYTOS Alternative
Cancer Treatment) using our next generation protocol since
2002.
Ashley Granot MD
Dr. Granot received his medical degree from Melbourne University
in 1973.
He has had many years of experience in family medicine and
over 20 years
experience in the fields of Phlebology, Cosmetic Medicine,
and Surgery, as
well as Nutritional and Environmental Medicine. He is a speaker
and a
teacher in the above fields of Medicine and Surgery and an
early exponent of
many procedures used today.
Dr. Granot brings to XYTOS an extensive list of global connections
in the
Medical field and is a tremendous asset to the future of XYTOS.
Credentials:
MBSS - Bachelor of Medicine, Bachelor of Surgery
FACNEM - Fellow, Australian College of Nutritional and Environmental
Medicine
FACCS - Fellow, Australian College of Cosmetic Surgeons
FACP - Fellow, Australian College of Phelbology
XYTOS will make a public announcement
with respect to
each additional member of the Medical / Scientific Advisory
Board and then post the CV's on this website for review.
|
